Zuellig, J.A.;                     Adam, R.;                     Udry, F.;                     Tibau, A.;                     Šeruga, B.;                     Ocaña, A.;                     Amir, E.;                     Templeton, A.J.    
        The Effect of Staging Intervals on Progression-Free Survival in Registration Studies of Oncologic Drugs: A Meta-Analysis. Cancers 2025, 17, 1359.
    https://doi.org/10.3390/cancers17081359
    AMA Style
    
                                Zuellig JA,                                 Adam R,                                 Udry F,                                 Tibau A,                                 Šeruga B,                                 Ocaña A,                                 Amir E,                                 Templeton AJ.        
                The Effect of Staging Intervals on Progression-Free Survival in Registration Studies of Oncologic Drugs: A Meta-Analysis. Cancers. 2025; 17(8):1359.
        https://doi.org/10.3390/cancers17081359
    
    Chicago/Turabian Style
    
                                Zuellig, Jonas A.,                                 Roman Adam,                                 Filomena Udry,                                 Ariadna Tibau,                                 Bostjan Šeruga,                                 Alberto Ocaña,                                 Eitan Amir,                                 and Arnoud J. Templeton.        
                2025. "The Effect of Staging Intervals on Progression-Free Survival in Registration Studies of Oncologic Drugs: A Meta-Analysis" Cancers 17, no. 8: 1359.
        https://doi.org/10.3390/cancers17081359
    
    APA Style
    
                                Zuellig, J. A.,                                 Adam, R.,                                 Udry, F.,                                 Tibau, A.,                                 Šeruga, B.,                                 Ocaña, A.,                                 Amir, E.,                                 & Templeton, A. J.        
        
        (2025). The Effect of Staging Intervals on Progression-Free Survival in Registration Studies of Oncologic Drugs: A Meta-Analysis. Cancers, 17(8), 1359.
        https://doi.org/10.3390/cancers17081359